Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis b
Phenotype C0024299|lymphoma
Sentences 22
PubMedID- 25030854 Primary hepatic mucosa-associated lymphoid tissue lymphoma and hemangioma with chronic hepatitis b virus infection as an underlying condition.
PubMedID- 25248874 Risk and prophylaxis strategy of hepatitis b virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab.
PubMedID- 24778676 Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in a patient with hepatitis b virus-related liver cirrhosis: a case report.
PubMedID- 24516927 [consensus on the management of lymphoma in patients with hepatitis b virus infection].
PubMedID- 26481866 Hepatosplenic t-cell lymphoma with coexistent hepatitis b infection: a rare clinicopathologic entity.
PubMedID- 26058465 This study aimed to assess hbv reactivation and hepatitis occurrence in diffuse large b-cell lymphoma (dlbcl) patients with resolved hepatitis b receiving rituximab-containing chemotherapy compared with hbsag-negative/hbcab-negative patients to identify risk factors for hbv reactivation and hepatitis occurrence and to analyze whether hbv reactivation and hepatitis affect the survival of dlbcl patients with resolved hepatitis b.
PubMedID- 25947024 [hepatic mucosa-associated lymphoid tissue lymphoma in a patient with chronic hepatitis b].
PubMedID- 22432084 The association of hepatitis b virus infection with b-cell non-hodgkin lymphoma - a review.
PubMedID- 23601025 Reactivation of hepatitis b virus in a patient with adult t-cell leukemia-lymphoma receiving the anti-cc chemokine receptor 4 antibody mogamulizumab.
PubMedID- 22783355 A large body of literature demonstrates the association of the hepatitis b virus (hbv) with malignant lymphoma [31, 58, 60, 61].
PubMedID- 24157019 Background: acute-on-chronic liver failure (aoclf) occurs in lymphoma patients because of hepatitis b virus (hbv) reactivation.
PubMedID- 24851363 [risk of reactivation of hepatitis b in patients with the lymphoma hbsag negative , anti-hbc positive treated with rituximab-chop].
PubMedID- 25803356 Treatment to prevent hepatitis b virus reactivation in patients with lymphoma receiving chemotherapy--reply.
PubMedID- 23429298 Hbv reactivation was more likely to occur in patients with lymphoma, high levels of hbv dna, or hepatitis b e antigen, and in men.
PubMedID- 25803354 Treatment to prevent hepatitis b virus reactivation in patients with lymphoma receiving chemotherapy.
PubMedID- 23606919 [12] reported that entecavir is more effective than lamivudine in preventing hepatitis b reactivation in patients with lymphoma under chemotherapy.
PubMedID- 21452121 [viral hepatitis b in a patient with follicular lymphoma treated with biological therapy].
PubMedID- 25848698 We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection.
PubMedID- 24367885 hepatitis b reactivation in patient with non-hodgkin's lymphoma receiving rituximab-based chemotherapy: need for education and attention.
PubMedID- 23529561 Primary hepatic lymphoma in a patient with chronic hepatitis b and c infection: diagnostic pitfalls and therapeutic challenge.
PubMedID- 21696249 We describe a case of severe acute hepatitis b developing in a patient with hodgkin's lymphoma after chemotherapy and before radiotherapy.
PubMedID- 23775967 Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis b virus reactivation in patients with lymphoma and resolved hepatitis b.

Page: 1